<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is a serious medical and economical problem of our times </plain></SENT>
<SENT sid="1" pm="."><plain>It is the most common <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal cancer</z:e> in the world </plain></SENT>
<SENT sid="2" pm="."><plain>In Poland, the treatment and detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> are poorly developed and the pathogenesis is still unclear </plain></SENT>
<SENT sid="3" pm="."><plain>One hypothesis suggests a role of reactive oxygen species (ROS) in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Experimental studies in recent years confirm the participation of ROS in the initiation and promotion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The aim of the study was to examine the effect of the following <z:chebi fb="0" ids="33240">coordination compounds</z:chebi> <z:chebi fb="0" ids="33240">coordination compounds</z:chebi>: dinitrate (V) tetra(3,4,5-trimethyl-N1-<z:chebi fb="0" ids="14973">pyrazole</z:chebi>-κN2) copper(II), dichloro di(3,4,5-trimethyl-N1-<z:chebi fb="0" ids="14973">pyrazole</z:chebi>-κN2) copper(II), dinitrate (V) di(1,4,5-trimethyl-N1-<z:chebi fb="0" ids="14973">pyrazole</z:chebi>-κN2) copper(II), dichloro di(1,3,4,5-tetramethyl-N1-<z:chebi fb="0" ids="14973">pyrazole</z:chebi>-κN2) copper(II) on the activity of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD, ZnCu-SOD) and catalase (CAT) in a group of patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and in the control group consisting of patients with minor gastrointestinal complaints </plain></SENT>
<SENT sid="6" pm="."><plain>MATERIAL AND METHODS: The study was conducted in 20 patients diagnosed with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> at the age of 66.5±10.2 years (10 men and 10 women) versus the control group of 20 people (10 men and 10 women) aged 57.89±17.10 years without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> lesions in the biological material - hemolysate prepared in a proportion of 1ml of water per 1 ml of blood </plain></SENT>
<SENT sid="7" pm="."><plain>CAT activity was measured by the Beers method (1952), while SOD activity was measured by the Misra and Fridovich method (1972) </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: We found that patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> showed a statistically significant decrease of SOD and CAT activity (CAT - 12,75±1.97 U/g Hb, SOD - 1111.52±155.52 U/g Hb) in comparison with the control group (CAT - 19.65±2,17 U/g Hb, SOD - 2046.26��507.22 U/g Hb) </plain></SENT>
<SENT sid="9" pm="."><plain>Simultaneously, we observed that the investigated <z:chebi fb="0" ids="33240">coordination compounds</z:chebi> of Cu(II) significantly increased the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity of CAT and SOD in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (mean: CAT 25.23±4.86 U/g Hb, SOD - 3075.96±940.20 U/g Hb) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> are characterized by reduced activity of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes catalase and <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase which suggests impaired <z:chebi fb="11" ids="22586">antioxidant</z:chebi> barrier </plain></SENT>
<SENT sid="11" pm="."><plain>Therefore, <z:chebi fb="0" ids="33240">coordination compounds</z:chebi> of Cu (II), which enhance the activity of CAT and SOD, may prove useful in the prevention and treatment of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>